Health Sciences Institute e-Alert Archives

Our daily e-letter, known as e-Alert, delivers health news—before anyone else. From overlooked studies to underground cures, it’s all here. Catch up on the insights that matter most.

Every weekday, our FREE e-Alert delivers urgent health breakthroughs and hidden dangers—before they hit the headlines.

Not signed up yet? Join 500,000+ readers worldwide by using the sign-up box below.

FILTERS
applied to search results for “Diabetes”

YEAR

CATEGORY

Browse the FULL e-Alert Archive using the filters in this section, or search for a specific topic below:


Search Results for “Diabetes” (1867 results found)

FDA confirms type 2 diabetes drug link to bladder cancer

June 22, 2011 As I told you earlier this week, France's drug authority recently told doctors to stop prescribing Actos based on a new study that links the type 2 diabetes drug to bladder cancer risk. Here in the U.S., FDA officials are not quite as cautious... Read More >

Categories: Actos bladder cancer FDA pioglitazone type 2 diabetes

Type 2 diabetics must avoid the Actos trap

June 20, 2011 You see, last year the FDA helped set a trap for type 2 diabetics with this shocking report: Over the past decade, it is estimated that 48,000 patients experienced stroke, heart failure, or death because they used Avandia instead of Actos (two best selling type 2 diabetes drugs... Read More >

Categories: Actos Avandia GlaxoSmithKline Takeda Pharmaceuticals type 2 diabetes

Muscle damage link to statin drugs goes deeper than we thought

June 16, 2011 Last spring, the FDA first warned that the highest dose of Zocor (a statin drug) may increase the risk of muscle damage. Now, more than a FULL YEAR later, the agency has finally gotten around to telling Merck (the maker of Zocor) to change the drug's label to show that... Read More >

Categories: arterial plaque Cataracts FDA kidney failure Lipitor liver damage memory loss Merck statin drugs type 2 diabetes Vytorin Zocor

Dietary supplement sabotaged by halt of major study

June 6, 2011 If you heard anything about this trial in the news, you probably heard that researchers were very disappointed that niacin proved to be useless in preventing cardiovascular events... Read More >

Categories: cardiovascular events NHLBI niacin Niaspan

An important warning for all diabetes patients

June 2, 2011 A recent CDC study shows that diabetics are at greater risk of developing several types of cancer, including cancers of the colon, breast, pancreas, kidney, prostate, and leukemia... Read More >

Categories: Diabetes link between diabetes and cancer liver cancer

NSAIDs are turning out to be more dangerous than anyone ever imagined

May 12, 2011 Extended use of non-steroidal anti-inflammatory drugs (NSAIDs) increases risk of gastrointestinal bleeding. What's less well known is that long-term use of prescription NSAIDs prompts well over 100,000 hospitalizations every year due to upper gastrointestinal adverse events... Read More >

Categories: ibuprofen side effects non-steroidal anti-inflammatory drugs NSAIDs NSAIDs cardiovascular disease

This vitamin is the key to protecting your liver and overall health

May 10, 2011 The disease is nonalcoholic fatty liver disease (NAFLD). It begins slowly, as fat accumulation in the liver. Then it becomes complicated by inflammation. Then liver scar tissue develops. Beyond that, the disease can play out in a number of different ways, as I mentioned above--all of them potentially deadly... Read More >

Categories: "silent epidemic" choline heart disease liver cancer NAFLD nonalcoholic fatty liver disease type 2 diabetes
Allan Spreen, M.D.
Dr. Allan Spreen, Chief Medical Advisor

Meet the Health Sciences Institute

The Health Sciences Institute (HSI) is an independent organization established in 1998. We’re dedicated to uncovering and researching the most urgent advances in modern underground medicine. Things you WON’T hear about in the mainstream.

Whether they come from a laboratory in Malaysia, a clinic in South America, or a university in Germany, our goal is to bring the treatments that work directly to the people who need them. We alert our Members to exciting breakthroughs in medicine, show them exactly where to go to learn more, and help them understand how they and their families can benefit from these powerful discoveries.

Learn More About the Health Sciences Institute. >